Literature DB >> 30246602

Clinical predictors of active LN development in children - evidence from the UK JSLE Cohort Study.

E M D Smith1, P Yin2, A L Jorgensen3, M W Beresford1.   

Abstract

BACKGROUND: Juvenile-onset systemic lupus erythematosus (JSLE) patients may develop lupus nephritis (LN) during their initial presentation, or later in their disease. This study aimed to assess whether clinical/demographic factors characterize patients with LN within the United Kingdom JSLE Cohort Study, and whether such factors predict subsequent LN development.
METHODS: Univariate logistic regression modelling compared clinical/demographic factors in patients with and without LN at baseline. For those who subsequently developed LN, Cox proportional-hazard modelling was used to test the association between such factors and time to LN development. Covariates with p < 0.2 univariately were included within a multiple-regression model.
RESULTS: A total of 121/331 (37%) patients presented with active LN at baseline, with first American College of Rheumatology (ACR) score ( p < 2.0 × 10-16), severe hypertension ( p = 0.0006), proteinuria ( p < 2.0 × 10-16), creatinine ( p = 1.0 × 10-16), erythrocyte sedimentation rate ( p = 1.0 × 10-16), neutrophils ( p < 2.0 × 10-16), complement 3 (C3) ( p = 4.0 × 10-16) and ethnicity ( p = 3.0 × 10-13) differing between those with and without LN. Of the 210 individuals without active LN at baseline, 13 patients had a single visit and were excluded from further analysis. Thirty-four of 197 (17%) developed LN after a median of 2.04 years (interquartile range, 0.8-3.7), with higher ACR scores ( p = 0.014 , hazard ratio (HR) = 1.45, 95% confidence interval (CI) = 1.08-1.95) and lower C3 levels ( p = 0.0082 , HR = 0.27, 95% CI = 0.10-0.68) demonstrated as predictors of subsequent LN.
CONCLUSIONS: Clinical and demographic factors can help to characterize patients at increased risk of LN.

Entities:  

Keywords:  JSLE; Juvenile-onset systemic lupus erythematosus; UK JSLE Cohort Study; active LN; lupus nephritis

Mesh:

Substances:

Year:  2018        PMID: 30246602     DOI: 10.1177/0961203318801526

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  2 in total

Review 1.  Management and outcomes in children with lupus nephritis in the developing countries.

Authors:  Priyanka Khandelwal; Srinivasavaradan Govindarajan; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2022-10-18       Impact factor: 3.651

2.  Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria.

Authors:  Kristina Vollbach; Catharina Schuetz; Christian M Hedrich; Fabian Speth; Kirsten Mönkemöller; Jürgen Brunner; Ulrich Neudorf; Christoph Rietschel; Anton Hospach; Tilmann Kallinich; Claas Hinze; Norbert Wagner; Burkhard Tönshoff; Lutz T Weber; Kay Latta; Julia Thumfart; Martin Bald; Dagobert Wiemann; Hildegard Zappel; Klaus Tenbrock; Dieter Haffner
Journal:  Front Pediatr       Date:  2022-04-22       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.